Table 1.
Summary of the clinical and pathological data
| PSA failure | |||||
|---|---|---|---|---|---|
| Total N = 117 |
Negative N = 60 |
Positive N = 57 |
p-value | ||
| Age | Mean (±SD) | 62.01 ± 6.06 | 62.35 ± 5.98 | 61.65 ± 5.21 | 0.53 |
| PSA-PRE surgery | 0–10 | 69 (61.1) | 42 (72.4) | 27 (49.1) | 0.04 |
| 10–20 | 31 (27.4) | 11 (19.0) | 20 (36.4) | ||
| > 20 | 13 (11.5) | 5 (8.6) | 8 (14.6) | ||
| GS | 6 | 16 (13.68) | 9 (15.00) | 7 (12.28) | 0.39 |
| 7 | 79 (67.52) | 43 (71.67) | 36 (63.16) | ||
| 8 | 17 (14.53) | 7 (11.67) | 10 (17.54) | ||
| 9 | 5 (4.27) | 1 (1.67) | 4 (7.02) | ||
| Tumor volume | Mean (±SD) | 26.52 ± 20.80 | 26.29 ± 19.30 | 26.78 ± 22.62 | 0.90 |
| EPE | No | 65 (55.56) | 37 (61.67) | 28 (49.12) | 0.17 |
| Yes | 52 (44.44) | 23 (38.33) | 29 (50.88) | ||
| SVI | No | 94 (80.34) | 49 (81.67) | 45 (78.95) | 0.71 |
| Yes | 23 (19.66) | 11 (18.33) | 12 (21.05) | ||
| Linear Length of the Margin | < 3 mm | 48 (41.38) | 28 (46.67) | 20 (35.71) | 0.23 |
| > = 3 mm | 68 (58.62) | 32 (53.33) | 36 (64.29) | ||
| KI67 at the Margin | 1 (no expression) | 64 (54.70) | 31 (51.67) | 33 (57.89) | 0.42 |
| 2 (weak expression) | 31 (26.50) | 19 (31.67) | 12 (21.05) | ||
| 3 (strong expression) | 22 (18.80) | 10 (16.67) | 12 (21.05) | ||
| Number of Margin | Single | 55 (47.01) | 30 (50.00) | 25 (43.86) | 0.51 |
| Multiple | 62 (52.99) | 30 (50.00) | 32 (56.14) | ||
| KI67-deep tumor | 1 (no expression) | 92 (78.63) | 49 (81.67) | 43 (75.44) | 0.71 |
| 2 (weak expression) | 11 (9.40) | 5 (8.33) | 6 (10.53) | ||
| 3 (strong expression) | 14 (11.97) | 6 (10.00) | 8 (14.04) | ||
| Adjuvant treatment | No | 55 (47.01) | 31 (51.67) | 24 (42.11) | 0.30 |
| Yes | 62 (52.99) | 29 (48.33) | 33 (57.89) | ||